Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest insulin pump Stories

2013-02-26 08:30:05

SAN DIEGO, Feb. 26, 2013 /PRNewswire/ -- Tandem Diabetes Care®, Inc. ("Tandem") today announced that its t:connect(TM) Diabetes Management Application, the web-based data management companion to the t:slim® Insulin Pump, has been cleared for use by the U.S. Food and Drug Administration (FDA). The t:connect Application is a Mac and PC-compatible data management software application that provides t:slim Pump users and their healthcare providers a fast, easy, and visual way to display...

2013-02-20 08:29:00

LAUSANNE and LES CHARBONNIERES, Switzerland, February 20, 2013 /PRNewswire/ -- Both Swiss companies, Debiotech SA and Valtronic SA, announced today that they have entered into an exclusive partnership agreement regarding the manufacturing of the electronic Controller unit for Debiotech's novel insulin "JewelPUMPTM". Representing the most advanced use of microfluidic MEMS (Micro-Electro-Mechanical Systems) technology in diabetes treatment, the watertight pump can be mounted on a...

2013-01-15 07:18:04

TORONTO, Jan. 15, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the continued increase in the prevalence of diabetes, combined with an expansion of insurance coverage as a consequence of healthcare reform, will cause the United States diabetes care device market to grow to nearly $16 billion by 2017. The market segments for continuous glucose monitoring (CGM) devices, insulin pumps and pens will exhibit even...

2013-01-08 08:31:38

SAN DIEGO, Jan. 8, 2013 /PRNewswire/ -- Tandem Diabetes Care, Inc. ("Tandem") announced today a partnership with JDRF, the leading global organization focused on type 1 diabetes (T1D) research, to develop a first-of-its-kind, dual-chamber infusion pump for the management of diabetes. The partnership agreement is designed to accelerate the development of a next-generation, fully automated artificial pancreas system using therapies in conjunction with insulin. "An ambulatory device that can...

2012-12-17 05:01:44

According to a new market report published by Transparency Market Research “Global Diabetes Devices Market and Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share and Forecast, 2011 — 2018,” the global diabetes devices and drugs market was worth USD 50.8 billion in 2011 and is expected to reach USD 98.4 billion in 2018, growing at a CAGR of 9.9% from 2011 to 2018. Browse the full report at...

2012-12-05 08:27:38

ARAD, Israel, December 5, 2012 /PRNewswire/ -- Andain Inc [http://www.andaininc.com ]. (OTCQB: ANDN [http://finance.yahoo.com/q?s=ANDN ]) ("Andain" or the "Company"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields, today discussed its breakthrough miniature fully disposable and programmable insulin pump. Andain's miniature insulin pump [http://www.andaininc.com/Default.asp?sType=0&PageId=15 ] is an ultra slim,...

2012-11-27 08:28:15

HORW, Switzerland, Nov. 27, 2012 /PRNewswire/ -- CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that the PaQ(® )Insulin Delivery Device has received CE Mark approval. PaQ has demonstrated the safety and efficacy required for marketing in Europe. PaQ is a discreet, wearable device that provides three days of consistent, basal insulin delivery as well as easy, on-demand bolus insulin for individuals with type 2 diabetes....

2012-11-12 08:25:01

BRIDGEWATER, N.J., Nov. 12, 2012 /PRNewswire/ -- Valeritas announced today the results from a recent retrospective analysis that looked at data relating to the clinical experience and feedback of patients with Type 2 diabetes who used the V-Go(TM), a wearable device for the delivery of insulin. The retrospective analysis of self-reported data from V-Go patients has been published in the current issue of Endocrine Practice, a peer-reviewed journal of the American College of Endocrinology and...

2012-11-08 12:28:22

YORK, Pa., Nov. 8, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced that its Precision-Therapy(TM) platform of bolus injection systems has been selected by a global pharmaceutical company to enter the next stage of collaboration as its preferred choice for long-duration subcutaneous drug delivery. Unilife has been advised that the global pharmaceutical company (the "Customer") is targeting more than five pipeline injectable drugs...

2012-10-25 11:26:11

SAN JOSE, California, October 25, 2012 /PRNewswire/ -- A new non-invasive continuous glucose monitor is approved for marketing in Europe C8 MediSensors, Inc. (http://www.c8medisensors.com) has today announced it received CE Mark approval for its Optical Glucose Monitor System, allowing the device, a new non-invasive continuous glucose monitor (nCGM), to be marketed in Europe. (Logo: http://photos.prnewswire.com/prnh/20121024/567690 ) The comprehensive,...